SCHEDULE: Deerfield Group Divests Oscar Health Stake to 0%

Deerfield Mgmt, L.P. and affiliated entities report 0% beneficial ownership in Oscar Health, Inc. Class A Common Stock.

Summary

• Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have filed an Amendment No. 3 to Schedule 13G.
• The filing indicates that these reporting persons now beneficially own 0% of Oscar Health, Inc.'s Class A Common Stock.
• This represents a complete divestment or reduction of their stake below the 5% reporting threshold.
• The event requiring this filing occurred on September 30, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the complete divestment by a significant institutional investor group, which can be interpreted as a lack of confidence or a strategic shift away from the company. However, the filing itself is purely factual and does not contain explicit negative commentary.

Negatives

• The reporting group, including Deerfield Mgmt, L.P. and James E. Flynn, no longer holds any beneficial ownership (0%) in Oscar Health, Inc. Class A Common Stock, indicating a full divestment or reduction below the reporting threshold.

Risks

• The complete divestment by a significant institutional investor group could be perceived as a negative signal by the market, potentially leading to increased volatility or investor uncertainty regarding Oscar Health, Inc.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Oscar Health, Inc.'s future performance or operations.

Industry Context

This filing reflects a change in an institutional investor's position in Oscar Health, Inc., a company operating in the healthcare technology and insurance sector. While not directly related to broader industry trends, significant investor exits can sometimes signal concerns within a specific company or sub-sector, though this filing provides no explicit reasons for the divestment.

Stakeholder Impact

• Shareholders: The divestment by a significant institutional investor could lead to negative market sentiment and potential downward pressure on Oscar Health, Inc.'s share price.

Key Dates

Recommendation

The filing reports a significant institutional investor group's complete divestment from Oscar Health, Inc. While this is a negative signal, the filing itself does not provide fundamental financial or operational details about Oscar Health, Inc. to warrant a 'sell' recommendation solely based on this information. Investors should 'hold' and monitor Oscar Health's upcoming financial reports and other market developments to understand the broader implications and the company's performance independent of this investor's exit.

Keywords

Oscar Health, Deerfield Management, Schedule 13G, Beneficial Ownership, Divestment, Institutional Investor, Healthcare Technology, Common Stock